发明名称 Rho kinase inhibitors
摘要 A compound represented by the formula (1): wherein R<1>-X- indicates that 1 to 4 R<1>-X- groups are present which may be the same or different, the ring A is a saturated or unsaturated 5-membered heterocyclic ring, X is a single bond, a group represented by the formula: -N(R<3>)-, -O- or -S-, or the like. R<1 >is a hydrogen atom, a halogen atom, a nitro group, a carboxyl group, a substituted or unsubstituted alkyl group, or the like, R<2 >is a hydrogen atom, a halogen atom, a nitro group, a carboxyl group, a substituted or unsubstituted alkyl group, or the like, and R<3 >is a hydrogen atom, a substituted or unsubstituted alkyl group, or the like; a prodrug of said compound, or a pharmaceutically acceptable salt of said compound or prodrug is a useful compound as a therapeutic agent for diseases for which Rho kinase is responsible.
申请公布号 US2004138286(A1) 申请公布日期 2004.07.15
申请号 US20030480526 申请日期 2003.12.12
申请人 IMAZAKI NAONORI;KITANO MASAFUMI;OHASHI NAOHITO;MATSUI KAZUKI 发明人 IMAZAKI NAONORI;KITANO MASAFUMI;OHASHI NAOHITO;MATSUI KAZUKI
分类号 A61P9/00;A61P9/10;A61P9/12;A61P13/02;A61P13/12;A61P15/00;A61P15/08;A61P19/08;A61P25/28;A61P27/02;A61P27/06;A61P29/00;A61P31/04;A61P31/18;A61P35/00;A61P37/02;A61P43/00;C07D231/56;C07D401/12;C07D403/12;C07D405/12;C07D409/12;C07D417/12;(IPC1-7):C07D209/04;C07D209/14;A61K31/405 主分类号 A61P9/00
代理机构 代理人
主权项
地址
您可能感兴趣的专利